Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer DL38684

This document is a response-to-comments notice regarding the MolDX Local Coverage Determination DL38684 for prognostic and predictive molecular classifiers for bladder cancer; it records the public comment period (05/28/2020–07/11/2020), notice period start (06/03/2021), and LCD effective date (07/18/2021). The provided text contains no substantive coverage criteria, indications, limitations, documentation requirements, or frequency limits; extraction of clinical criteria is not possible from the supplied excerpt and requires review of the full LCD DL38684 content.